Securities and Exchange Commission
Washington, D.C. 20549
Form 6-K
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d/16
of the Securities Exchange Act of 1934
June 2015
AEGON N.V.
Aegonplein 50
2591 TV THE HAGUE
The Netherlands
Aegons press release, dated June 17, 2015, is included as appendix and incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AEGON N.V. | ||||||
(Registrant) | ||||||
Date: June 17, 2015 | By | /s/ J.O. van Klinken | ||||
J.O. van Klinken | ||||||
Executive Vice President and | ||||||
General Counsel |
The Hague June 17, 2015
Aegon determines stock fraction 2014 final dividend and announces that it will repurchase shares to neutralize stock dividend
Shareholders were given the opportunity to choose between receiving the 2014 final dividend of EUR 0.12 per common share in cash or in stock. 42% of shareholders elected to receive the stock dividend. Those who elected for a stock dividend will receive one Aegon common share for every 55 common shares held. The stock fraction is based on Aegons average share price as quoted on Euronext Amsterdam, using the high and low of each of the five trading days from June 8 up to and including June 12, 2015. The average share price calculated on this basis amounted to EUR 6.62. The stock dividend and the cash dividend are approximately equal in value.
Aegon will repurchase 16,279,933 common shares to neutralize the dilutive effect of the 2014 final stock dividend. These shares will be held as treasury shares and will be used to pay future stock dividends. Aegon is committed to the repurchase of the common shares by engaging a third party to execute the transactions on its behalf. These transactions will commence on June 17, 2015, and are expected to be completed on or before July 14, 2015. The common shares will be repurchased at a maximum of the daily volume-weighted average price. Aegon will provide weekly updates regarding the transactions on aegon.com/sharebuyback.
Media relations | Investor relations | |
Dick Schiethart | Willem van den Berg | |
+31 (0) 70 344 8821 | +31 (0) 70 344 8305 | |
gcc@aegon.com | ir@aegon.com |
Aegons roots go back more than 150 years to the first half of the nineteenth century. Since then, Aegon has grown into an international company, with businesses in more than 20 countries in the Americas, Europe and Asia. Today, Aegon is one of the worlds leading financial services organizations, providing life insurance, pensions and asset management. Aegons purpose is to help people take responsibility for their financial future. More information: aegon.com.
DISCLAIMERS
Forward-looking statements
The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:
| Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; |
| Changes in the performance of financial markets, including emerging markets, such as with regard to: |
| The frequency and severity of defaults by issuers in Aegons fixed income investment portfolios; |
| The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and |
| The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that Aegon holds; |
| Changes in the performance of Aegons investment portfolio and decline in ratings of Aegons counterparties; |
| Consequences of a potential (partial) break-up of the euro; |
| The frequency and severity of insured loss events; |
| Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegons insurance products; |
| Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations; |
| Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; |
| Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; |
| Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness; |
| Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; |
| Changes in laws and regulations, particularly those affecting Aegons operations, ability to hire and retain key personnel, the products Aegon sells, and the attractiveness of certain products to its consumers; |
| Regulatory changes relating to the insurance industry in the jurisdictions in which Aegon operates; |
| Changes in customer behavior and public opinion in general related to, among other things, the type of products also Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations; |
| Acts of God, acts of terrorism, acts of war and pandemics; |
| Changes in the policies of central banks and/or governments; |
| Lowering of one or more of Aegons debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegons ability to raise capital and on its liquidity and financial condition; |
| Lowering of one or more of insurer financial strength ratings of Aegons insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of its insurance subsidiaries; |
| The effect of the European Unions Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain; |
| Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business; |
| As Aegons operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt Aegons business, damage its reputation and adversely affect its results of operations, financial condition and cash flows; |
| Customer responsiveness to both new products and distribution channels; |
| Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegons products; |
| Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, may affect Aegons reported results and shareholders equity; |
| The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegons ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; |
| Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt Aegons business; and |
| Aegons failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving and excess capital and leverage ratio management initiatives. |
Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegons expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
2